Company Filing History:
Years Active: 2019
Title: **Innovative Contributions of Inventor Xiaoshan Su**
Introduction
Xiaoshan Su is a notable inventor based in Shenzhen, China. With a keen focus on enhancing sequencing technology, he has made significant strides in the field. His innovative work has led to the development of a unique linker element that advances the construction of sequencing libraries, addressing critical efficiency issues.
Latest Patents
Su holds a patent for a "Linker element and method of using same to construct sequencing library." This invention provides a linker element that comprises two distinct components: linker A and linker B. Linker A is designed through the complementary pairing of a long nucleic acid strand and a short nucleic acid strand, featuring specific modifications that enhance functionality. Linker B serves as a single-strand nucleic acid, designed for complementary pairing. This innovation improves directionality in linking processes, resolves interlinking challenges, and reduces costs associated with sequencing library construction.
Career Highlights
Xiaoshan Su is currently affiliated with MGI Tech Co., Ltd., where he leverages his expertise in sequencing technologies. His work focuses on developing advanced solutions that meet the demands of modern scientific research. With a single patent to his name, Su has begun establishing himself as an influential figure in the biotechnology sector.
Collaborations
Throughout his career, Su has collaborated with talented colleagues, including Yuan Jiang and Chunyu Geng. These partnerships foster an environment of innovation and creativity, contributing to the success of their projects at MGI Tech Co., Ltd.
Conclusion
In summary, inventor Xiaoshan Su is making a mark in the field of sequencing technologies with his innovative linker element patent. His work not only addresses existing challenges in the industry but also sets the stage for future advancements. Through collaboration and dedication, Su continues to shape the landscape of biotechnology in significant ways.